BENEVICH ERIC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
42
Insider Sells Sum
$30.28M

Insider Activity of BENEVICH ERIC

According to the SEC Form 4 filings, BENEVICH ERIC, being in a position of

  1. Chief Commercial Officer at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8124 shares for $1.24M,
    over all time since 2017-02-06, has bought 0 shares, and sold 262515 shares for $31.52M.

Biography of BENEVICH ERIC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,238,9112100

Comparison of Insiders on Amount of Buys and Sells

2026-09-09SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
2,154
0.0021%
$154.61$333,030-7.71%
2025-11-28SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
5,970
0.006%
$151.74$905,881-4.48%
2025-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
2,154
0.0021%
$116.73$251,428+14.2%
2025-02-10SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
980
0.0009%
$118.31$115,940+12.24%
2025-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,207
0.0012%
$152.94$184,599-12.38%
2024-04-15SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
12,587
0.0128%
$133.36$1.68M+0.61%
2024-03-14SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
69,521
0.0689%
$139.38$9.69M-2.74%
2024-02-28SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
21,857
0.0219%
$134.69$2.94M+0.87%
2024-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,098
0.0011%
$133.01$146,050+1.56%
2024-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
980
0.0009%
$134.19$131,509+1.15%
2024-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,280
0.0013%
$142.12$181,910-4.88%
2024-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,207
0.0012%
$140.78$169,927-2.7%
2023-08-21SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,600
0.0016%
$107.40$171,836+23.68%
2023-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
980
0.001%
$104.12$102,036+0.27%
2023-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
17,390
0.0177%
$102.41$1.78M+0.81%
2023-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,280
0.0013%
$105.63$135,201-0.44%
2023-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
1,207
0.0012%
$109.95$132,710-5.74%
2023-01-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
400
0.0004%
$125.00$50,000-15.03%
2022-11-30SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
20,063
0.0206%
$125.90$2.53M-17.71%
2022-11-10SaleNeurocrine Biosciences, Inc.
NBIX
Chief Commercial Officer
100
0.0001%
$125.36$12,536-15.14%
Total: 44
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.